Literature DB >> 22243045

Neurocognition and neuroimaging of persistent negative symptoms of schizophrenia.

Cindy L Hovington1, Martin Lepage.   

Abstract

Negative symptoms have been a conundrum to researchers and clinicians alike since having first been identified by Bleuler and Kraepelin. The term 'negative symptoms' has been scrutinized with regards to what it encompasses. Negative symptomatology has been categorized into distinct subdomains, including primary symptoms, secondary symptoms, deficit syndrome and, more recently, persistent negative symptoms (PNS). Although there have been some theories put forward with regards to negative symptoms, there are still discordant findings regarding PNS. Thus, this article aimed to review the structural, functional and cognitive correlates of PNS in an attempt to better understand these specific negative symptoms in schizophrenia. According to the reviewed literature, deficit syndrome appears to have similar neurocognitive and structural deficits as PNS; however, some minor distinctions may suggest that PNS are a separate subtype of negative symptoms. White matter decrements in the frontal lobe and gray matter reductions in the temporal lobe may be related more specifically to PNS. Furthermore, unlike deficit syndrome, structural abnormalities in the frontal and temporal lobe also appear to be related to PNS in patients with first-episode schizophrenia. Cognitive domains, such as memory, are impaired and appear to be predominantly related to PNS. Hence, PNS do appear to have neuroimaging and neurocognitive correlates and warrant further research.

Entities:  

Mesh:

Year:  2012        PMID: 22243045     DOI: 10.1586/ern.11.173

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  16 in total

Review 1.  Neurocognition: clinical and functional outcomes in schizophrenia.

Authors:  Martin Lepage; Michael Bodnar; Christopher R Bowie
Journal:  Can J Psychiatry       Date:  2014-01       Impact factor: 4.356

2.  Neural substrate of unrelenting negative symptoms in schizophrenia: a longitudinal resting-state fMRI study.

Authors:  Mingli Li; Wei Deng; Tushar Das; Yinfei Li; Liansheng Zhao; Xiaohong Ma; Yingcheng Wang; Hua Yu; Xiaojing Li; Ya-Jing Meng; Qiang Wang; Lena Palaniyappan; Tao Li
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-11-11       Impact factor: 5.270

3.  Convergence and Divergence of Brain Network Dysfunction in Deficit and Non-deficit Schizophrenia.

Authors:  Miao Yu; Zhengjia Dai; Xiaowei Tang; Xiang Wang; Xiaobin Zhang; Weiwei Sha; Shuqiao Yao; Ni Shu; Xindi Wang; Jiaying Yang; Xiangyang Zhang; Xiangrong Zhang; Yong He; Zhijun Zhang
Journal:  Schizophr Bull       Date:  2017-10-21       Impact factor: 9.306

Review 4.  Neurobiological background of negative symptoms.

Authors:  Silvana Galderisi; Eleonora Merlotti; Armida Mucci
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-03-24       Impact factor: 5.270

5.  Prefrontal Transcranial Direct Current Stimulation for Treatment of Schizophrenia With Predominant Negative Symptoms: A Double-Blind, Sham-Controlled Proof-of-Concept Study.

Authors:  Ulrich Palm; Daniel Keeser; Alkomiet Hasan; Michael J Kupka; Janusch Blautzik; Nina Sarubin; Filipa Kaymakanova; Ina Unger; Peter Falkai; Thomas Meindl; Birgit Ertl-Wagner; Frank Padberg
Journal:  Schizophr Bull       Date:  2016-04-20       Impact factor: 9.306

Review 6.  Pharmacogenomics can improve antipsychotic treatment in schizophrenia.

Authors:  Qingqing Xu; Xi Wu; Yuyu Xiong; Qinghe Xing; Lin He; Shengying Qin
Journal:  Front Med       Date:  2013-04-21       Impact factor: 4.592

7.  Contingent Negative Variation Blunting and Psychomotor Dysfunction in Schizophrenia: A Systematic Review.

Authors:  K Juston Osborne; Brian Kraus; Phoebe H Lam; Teresa Vargas; Vijay A Mittal
Journal:  Schizophr Bull       Date:  2020-03-27       Impact factor: 9.306

8.  Identifying persistent negative symptoms in first episode psychosis.

Authors:  Cindy L Hovington; Michael Bodnar; Ridha Joober; Ashok K Malla; Martin Lepage
Journal:  BMC Psychiatry       Date:  2012-12-06       Impact factor: 3.630

9.  Cortical thinning in temporo-parietal junction (TPJ) in non-affective first-episode of psychosis patients with persistent negative symptoms.

Authors:  Michael Bodnar; Cindy L Hovington; Lisa Buchy; Ashok K Malla; Ridha Joober; Martin Lepage
Journal:  PLoS One       Date:  2014-06-30       Impact factor: 3.240

10.  The relationship between neurocognition and symptomatology in people with schizophrenia: social cognition as the mediator.

Authors:  Bess Y H Lam; Adrian Raine; Tatia M C Lee
Journal:  BMC Psychiatry       Date:  2014-05-13       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.